stockportfolio.pro
Amphastar Pharmaceuticals, Inc. Net Income 2012–2025
Amphastar Pharmaceuticals, Inc. (AMPH) annual net income by fiscal year, computed from SEC filings. Compound growth +13.9%/yr over 13 years.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $98.09M | 13.6% | -38.5% |
| FY 2024 | $159.52M | 21.8% | +16.0% |
| FY 2023 | $137.54M | 21.3% | +50.5% |
| FY 2022 | $91.39M | 18.3% | +47.1% |
| FY 2021 | $62.12M | 14.2% | +4327.4% |
| FY 2020 | $1.40M | 0.4% | -97.1% |
| FY 2019 | $48.94M | 15.2% | +952.9% |
| FY 2018 | $-5.74M | -1.9% | -257.3% |
| FY 2017 | $3.65M | 1.5% | -62.9% |
| FY 2016 | $9.82M | 3.8% | +452.4% |
| FY 2015 | $-2.79M | -1.1% | +74.0% |
| FY 2014 | $-10.70M | -5.1% | -190.2% |
| FY 2013 | $11.86M | 5.2% | -34.4% |
| FY 2012 | $18.09M | 8.9% | — |
Source: Amphastar Pharmaceuticals, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Amphastar Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAmphastar Pharmaceuticals, Inc. — frequently asked questions
What is Amphastar Pharmaceuticals, Inc.'s net income?
Amphastar Pharmaceuticals, Inc. (AMPH) reported net income of $98.09M for fiscal year 2025, per its SEC filings.
How has Amphastar Pharmaceuticals, Inc.'s net income changed over time?
Between fiscal 2012 and 2025, AMPH's net income grew at roughly 13.9% per year (compound annual rate), from $18.09M to $98.09M.
Where does this data come from?
Figures are computed from Amphastar Pharmaceuticals, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.